The performance of quality controls in the Investigator® Quantiplex® Pro RGQ and Investigator® 24plex STR kits with a variety of forensic samples.

Challenging samples Forensic DNA Investigator 24plex GO! Investigator 24plex QS Investigator Quantiplex Pro RGQ QS markers

Journal

Forensic science international. Genetics
ISSN: 1878-0326
Titre abrégé: Forensic Sci Int Genet
Pays: Netherlands
ID NLM: 101317016

Informations de publication

Date de publication:
11 2021
Historique:
received: 31 03 2021
revised: 20 08 2021
accepted: 22 08 2021
pubmed: 17 9 2021
medline: 26 11 2021
entrez: 16 9 2021
Statut: ppublish

Résumé

Forensic DNA laboratories process database reference samples on FTA® cards or buccal swabs, which commonly contain adequate amounts of quality DNA resulting in full STR profiles and high first-pass rates. However, some reference samples and many forensic casework samples are exposed to a variety of insults that may lead to low quantities of DNA, DNA degradation, DNA mixtures, and/or PCR inhibition, posing a challenge to downstream genotyping success. The inclusion of multiple amplification targets and internal PCR controls (IPCs) in DNA quantification kits, and quality sensors within STR amplification kits can aid in the accurate interpretation of sample/profile quality, and guide more efficient rework strategies when needed. In order to assess the effectiveness of these quality systems we subjected database-type samples (buccal swabs and blood or saliva on FTA® cards), mock casework samples (low-template, degraded, inhibited, DNA mixtures), and authentic post-coital samples to various challenging conditions. Concordance between the quality flags in the Investigator® Quantiplex® Pro RGQ kit (QIAGEN), the QS markers in QIAGEN's Investigator® 24plex QS kit, and overall STR profile quality was evaluated for all casework-type samples. To assess the value of the QS markers in the Investigator® 24plex QS and GO! STR kits, samples with partial or failed STR profiles were reworked based on the quality of the electropherogram first with the QS markers redacted, and second in conjunction with the QS markers. Results from each of the rework approaches were compared to determine which strategy, if any, improved the STR profile quality and the number of reportable alleles. The QS markers in the 24plex STR kits correctly confirmed sample quality in 99.9% of databasing samples and 98% of mock casework samples. Quality flags during DNA quantification were concordant with downstream STR profiles for the majority (77%) of the mock casework samples. Additionally, when samples with partial STR profiles were reworked, more loci were obtained for 80% of the samples regardless of the rework strategy used. However, the most notable improvement in STR completeness was observed in inhibited samples that were reworked based on the information provided by the STR quality sensors, with an average increase of 56% reportable alleles.

Identifiants

pubmed: 34530399
pii: S1872-4973(21)00123-X
doi: 10.1016/j.fsigen.2021.102586
pii:
doi:

Substances chimiques

DNA 9007-49-2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102586

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Michelle Harrel (M)

Department of Forensic Science, Sam Houston State University, Huntsville, TX, USA. Electronic address: mharrel@signaturescience.com.

Carrie Mayes (C)

Department of Forensic Science, Sam Houston State University, Huntsville, TX, USA.

Rachel Houston (R)

Department of Forensic Science, Sam Houston State University, Huntsville, TX, USA.

Amy S Holmes (AS)

Department of Forensic Science, Sam Houston State University, Huntsville, TX, USA.

Ryan Gutierrez (R)

Department of Forensic Science, Sam Houston State University, Huntsville, TX, USA.

Sheree Hughes (S)

Department of Forensic Science, Sam Houston State University, Huntsville, TX, USA; School of Biomedical Sciences, Faculty of Medicine, University of Queensland, QLD, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH